CN113396898B - 不中断血流器官灌注装置和灌注方法 - Google Patents
不中断血流器官灌注装置和灌注方法 Download PDFInfo
- Publication number
- CN113396898B CN113396898B CN202110881747.2A CN202110881747A CN113396898B CN 113396898 B CN113396898 B CN 113396898B CN 202110881747 A CN202110881747 A CN 202110881747A CN 113396898 B CN113396898 B CN 113396898B
- Authority
- CN
- China
- Prior art keywords
- organ
- container
- flow path
- perfusion
- branch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 264
- 230000010412 perfusion Effects 0.000 title claims abstract description 198
- 238000000034 method Methods 0.000 title claims abstract description 53
- 230000017531 blood circulation Effects 0.000 title claims abstract description 38
- 210000004369 blood Anatomy 0.000 claims abstract description 88
- 239000008280 blood Substances 0.000 claims abstract description 88
- 238000002054 transplantation Methods 0.000 claims abstract description 34
- 230000008569 process Effects 0.000 claims abstract description 32
- 230000036770 blood supply Effects 0.000 claims abstract description 18
- 230000033228 biological regulation Effects 0.000 claims description 87
- 238000001514 detection method Methods 0.000 claims description 79
- 210000003240 portal vein Anatomy 0.000 claims description 56
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 47
- 229910052760 oxygen Inorganic materials 0.000 claims description 47
- 239000001301 oxygen Substances 0.000 claims description 47
- 239000012530 fluid Substances 0.000 claims description 42
- 239000007789 gas Substances 0.000 claims description 39
- 238000003306 harvesting Methods 0.000 claims description 39
- 230000004087 circulation Effects 0.000 claims description 37
- 230000001105 regulatory effect Effects 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 35
- 210000001631 vena cava inferior Anatomy 0.000 claims description 34
- 238000001802 infusion Methods 0.000 claims description 25
- 210000002767 hepatic artery Anatomy 0.000 claims description 21
- 238000011049 filling Methods 0.000 claims description 20
- 230000000004 hemodynamic effect Effects 0.000 claims description 20
- 238000011156 evaluation Methods 0.000 claims description 19
- 238000006213 oxygenation reaction Methods 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 17
- 230000003204 osmotic effect Effects 0.000 claims description 16
- 238000004321 preservation Methods 0.000 claims description 15
- 230000028327 secretion Effects 0.000 claims description 13
- 238000000338 in vitro Methods 0.000 claims description 11
- 206010053459 Secretion discharge Diseases 0.000 claims description 9
- 238000009413 insulation Methods 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 238000004393 prognosis Methods 0.000 abstract description 7
- 238000003860 storage Methods 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 description 109
- 210000001367 artery Anatomy 0.000 description 43
- 210000000952 spleen Anatomy 0.000 description 36
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 22
- 210000000941 bile Anatomy 0.000 description 17
- 230000008859 change Effects 0.000 description 17
- 210000003128 head Anatomy 0.000 description 16
- 239000000306 component Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 229940079593 drug Drugs 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 11
- 235000014655 lactic acid Nutrition 0.000 description 11
- 210000005229 liver cell Anatomy 0.000 description 11
- 238000001931 thermography Methods 0.000 description 11
- 210000003462 vein Anatomy 0.000 description 11
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 10
- 108010082126 Alanine transaminase Proteins 0.000 description 10
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 10
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 10
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 10
- 229960004657 indocyanine green Drugs 0.000 description 10
- 238000012545 processing Methods 0.000 description 9
- 206010063837 Reperfusion injury Diseases 0.000 description 8
- 238000000799 fluorescence microscopy Methods 0.000 description 8
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 239000011664 nicotinic acid Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000005239 tubule Anatomy 0.000 description 7
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 6
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000028867 ischemia Diseases 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000000302 ischemic effect Effects 0.000 description 5
- 230000001706 oxygenating effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 210000002889 endothelial cell Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 230000010224 hepatic metabolism Effects 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 230000000250 revascularization Effects 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000008321 arterial blood flow Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010040742 Sinus congestion Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 206010047163 Vasospasm Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000037906 ischaemic injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- ZUHFPYANLLWSJR-UHFFFAOYSA-N 4,5,6,7-tetraiodo-1h-benzimidazole Chemical compound IC1=C(I)C(I)=C2NC=NC2=C1I ZUHFPYANLLWSJR-UHFFFAOYSA-N 0.000 description 1
- 208000015163 Biliary Tract disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 208000034706 Graft dysfunction Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 108700042768 University of Wisconsin-lactobionate solution Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013156 embolectomy Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 210000002989 hepatic vein Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002530 ischemic preconditioning effect Effects 0.000 description 1
- 231100000832 liver cell necrosis Toxicity 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000000082 organ preservation Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000005077 saccule Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
- A01N1/0247—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
Abstract
Description
Claims (14)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110881747.2A CN113396898B (zh) | 2021-08-02 | 2021-08-02 | 不中断血流器官灌注装置和灌注方法 |
PCT/CN2021/130446 WO2023010708A1 (zh) | 2021-08-02 | 2021-11-12 | 不中断血流器官灌注装置和灌注方法 |
US17/575,505 US11528903B1 (en) | 2021-08-02 | 2022-01-13 | Ischaemia-free organ perfusion device and perfusion method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110881747.2A CN113396898B (zh) | 2021-08-02 | 2021-08-02 | 不中断血流器官灌注装置和灌注方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113396898A CN113396898A (zh) | 2021-09-17 |
CN113396898B true CN113396898B (zh) | 2021-11-09 |
Family
ID=77688317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110881747.2A Active CN113396898B (zh) | 2021-08-02 | 2021-08-02 | 不中断血流器官灌注装置和灌注方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11528903B1 (zh) |
CN (1) | CN113396898B (zh) |
WO (1) | WO2023010708A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113396898B (zh) * | 2021-08-02 | 2021-11-09 | 中山大学附属第一医院 | 不中断血流器官灌注装置和灌注方法 |
CN115316375B (zh) * | 2022-08-15 | 2023-08-18 | 四川大学华西医院 | 一种用于腹部器官移植供体灌注的一体式穿刺灌注导管 |
CN117547672B (zh) * | 2024-01-02 | 2024-04-05 | 中山大学附属第一医院 | 一种基于dcd的体外腹腔脏器灌注及移植系统 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03151302A (ja) * | 1989-11-04 | 1991-06-27 | Olympus Optical Co Ltd | 潅流装置 |
CN1320014A (zh) * | 1998-09-29 | 2001-10-31 | 器官恢复体系股份有限公司 | 维持和/或恢复器官生存力的装置和方法 |
WO2007111495A1 (en) * | 2006-03-28 | 2007-10-04 | Organ Assist B.V. | A method and a system for prolongation of the viability of a donor organ |
CN108432743A (zh) * | 2018-06-15 | 2018-08-24 | 广州军区广州总医院 | 便携式器官捐献供体机械灌注系统 |
CN209711249U (zh) * | 2019-02-01 | 2019-12-03 | 陈建轩 | 一种肾脏灌注装置 |
CN112244007A (zh) * | 2020-09-27 | 2021-01-22 | 中山大学附属第一医院 | 一种智能化离体器官长期维护装置 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100082A (en) * | 1997-09-23 | 2000-08-08 | Hassanein; Waleed H. | Perfusion apparatus and method including chemical compositions for maintaining an organ |
EP2750499B1 (en) * | 2011-09-02 | 2016-07-20 | Organ Assist B.V. | Apparatus, system and method for conditioning and preserving an organ from a donor |
EP2893806B1 (en) * | 2012-09-08 | 2019-04-17 | Organ Technologies, Inc. | Method for maintaining organ or tissue for transplantation use for long period |
US10278384B2 (en) * | 2014-02-04 | 2019-05-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Endovascular apparatus for perfusing organs in a body |
US20200375178A1 (en) * | 2018-01-19 | 2020-12-03 | Eth Zurich | Perfusion Loop Assembly for an Ex-Vivo Liver Perfusion and a Method for Ex-Vivo Liver Perfusion |
US20200108109A1 (en) * | 2018-10-05 | 2020-04-09 | Duke University | Methods for the Delivery of Therapeutic Agents to Donor Organs |
CN109511649B (zh) | 2018-11-21 | 2021-06-25 | 嘉兴莱普晟医疗科技有限公司 | 一种可以扩大供肝来源的常温机械灌注系统 |
CN109362710B (zh) | 2018-11-28 | 2020-03-10 | 广东丁沃生医疗器械有限公司 | 肝脏灌注装置 |
CN111869657A (zh) | 2020-08-17 | 2020-11-03 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | 离体肝脏灌注系统、接头管组件及其连接方法 |
CN113396898B (zh) * | 2021-08-02 | 2021-11-09 | 中山大学附属第一医院 | 不中断血流器官灌注装置和灌注方法 |
-
2021
- 2021-08-02 CN CN202110881747.2A patent/CN113396898B/zh active Active
- 2021-11-12 WO PCT/CN2021/130446 patent/WO2023010708A1/zh unknown
-
2022
- 2022-01-13 US US17/575,505 patent/US11528903B1/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03151302A (ja) * | 1989-11-04 | 1991-06-27 | Olympus Optical Co Ltd | 潅流装置 |
CN1320014A (zh) * | 1998-09-29 | 2001-10-31 | 器官恢复体系股份有限公司 | 维持和/或恢复器官生存力的装置和方法 |
WO2007111495A1 (en) * | 2006-03-28 | 2007-10-04 | Organ Assist B.V. | A method and a system for prolongation of the viability of a donor organ |
CN108432743A (zh) * | 2018-06-15 | 2018-08-24 | 广州军区广州总医院 | 便携式器官捐献供体机械灌注系统 |
CN209711249U (zh) * | 2019-02-01 | 2019-12-03 | 陈建轩 | 一种肾脏灌注装置 |
CN112244007A (zh) * | 2020-09-27 | 2021-01-22 | 中山大学附属第一医院 | 一种智能化离体器官长期维护装置 |
Also Published As
Publication number | Publication date |
---|---|
US11528903B1 (en) | 2022-12-20 |
CN113396898A (zh) | 2021-09-17 |
WO2023010708A1 (zh) | 2023-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113396898B (zh) | 不中断血流器官灌注装置和灌注方法 | |
JP6887045B2 (ja) | エクスビボ肺ケアのためのシステムおよび方法 | |
WO2020192513A1 (zh) | 一种生物体器官的机械灌注保存装置 | |
US7410474B1 (en) | Methods and means for extracorporeal organ perfusion | |
US8329450B2 (en) | Methods and apparatus for organ support | |
JP2011511000A5 (zh) | ||
WO2001093922A1 (en) | Method and apparatus for cerebral tempering | |
Duignan et al. | A multi-mode system for myocardial functional and physiological assessment during ex situ heart perfusion | |
EP4344543A1 (en) | Device for the storage and preservation of an organ to be perfused with an ex vivo perfusion system | |
US20230073834A1 (en) | Subnormothermic machine perfusion of organs with carbon monoxide and oxygen | |
CN109619091B (zh) | 一种肾脏灌注装置 | |
Forgie et al. | Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism | |
Spencer et al. | Twenty-four-hour Normothermic Ex Vivo Heart Perfusion With Low Flow Functional Assessment in an Adult Porcine Model | |
Koehler et al. | Organ Perfusion and Cardiopulmonary Bypass Techniques | |
WO2023250497A2 (en) | Systems and methods for customized pulsatile perfusion control | |
Becker | Development of a long-term ex vivo liver perfusion system | |
Gullón Vega | Normothermic perfusion ofan isolated liver: control software implementation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220329 Address after: 510000 floor 5, building 5, No. 51, Xiangshan Avenue, Ningxi street, Zengcheng District, Guangzhou, Guangdong Patentee after: Singularity medical technology (Guangzhou) Co.,Ltd. Address before: 510062 self made room a40, 505, west block, No. 2, Shuiyin Road, Yuexiu District, Guangzhou, Guangdong Province (office only) Patentee before: Tianyige medical technology (Guangzhou) Co.,Ltd. Effective date of registration: 20220329 Address after: 510062 self made room a40, 505, west block, No. 2, Shuiyin Road, Yuexiu District, Guangzhou, Guangdong Province (office only) Patentee after: Tianyige medical technology (Guangzhou) Co.,Ltd. Address before: 510080 No. two, No. 58, Zhongshan Road, Guangdong, Guangzhou Patentee before: THE FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN University |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20210917 Assignee: THE FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN University Assignor: Singularity medical technology (Guangzhou) Co.,Ltd. Contract record no.: X2024980004045 Denomination of invention: Non interrupting blood flow organ perfusion device and perfusion method Granted publication date: 20211109 License type: Common License Record date: 20240408 |